Skip to main content

Table 3 Pain measurements of patients separated into the six age ranges

From: Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints

Age range (years)

Relative mean VAS score

Hip bone (AVN)

Knee and Hip cartilage

Combined

 

Pre

1 mo.

3 mo.

Pre

1 mo.

3 mo.

Pre

1 mo.

3 mo.

18 ~ 29

10

8.50 ± 0.33

-

10

5.80 ± 1.40

3.00 ± 0.62

10

6.57 ± 1.53

3.00 ± 1.38

30 ~ 39

10

5.20 ± 0.83

3.40 ± 0.54

10

7.71 ± 0.75

5.86 ± 0.89

10

6.67 ± 1.30

4.83 ± 1.64

40 ~ 49

10

6.33 ± 0.25

6.33 ± 0.23

10

6.38 ± 1.67

4.45 ± 1.59

10

6.28 ± 1.71

4.89 ± 1.97

50 ~ 59

10

10*

6*

10

6.81 ± 1.10

4.21 ± 1.27

10

7.20 ± 1.16

4.31 ± 1.99

60 ~ 69

10

9*

9*

10

6.75 ± 1.85

4.97 ± 1.60

10

6.75 ± 1.83

5.21 ± 1.92

70 ~ 80

-

-

-

10

5.00 ± 0.69

2.44 ± 0.62

10

5.00 ± 0.97

2.44 ± 1.93

  1. Pre: pre-treatment; 1 mo.: one month after treatment; 3 mo.: three months after treatment; -: not determined; *: VAS score of one patient.